Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2006

View Archived Issues

COL-3 shows promise in AIDS-related Kaposi's sarcoma

Matuzumab/gemcitabine combination feasible in pancreatic cancer

Elemene inhibits laryngeal cancer cell growth

Activity of BXL-628 indicative of efficacy in overactive bladder

DDP-225 improves bladder irritation and capacity in animal models

IP-751 demonstrates efficacy against bladder irritation in vivo

Vertex begins clinical trial for potential cystic fibrosis treatment

Arginox continues to enroll TRIUMPH trial for cardiogenic shock

R-343 selected for advanced preclinical development as allergic asthma treatment

Neotropix's oncolytic virus candidate SVV-001 cleared for clinical trials

Biosite voluntarily withdraws PMA for Triage Stroke Panel

Amarin acquires rights to novel formulation of apomorphine

Agreement for preclinical testing of synDNA H5N1 avian flu vaccine candidates

Terumo and Yakult Honsha to codevelopment liposomal irinotecan

deCODE advances DG-031 to phase III for heart attack prevention

New spinout Cabrellis Pharmaceuticals begins operations

Collaboration to develop treatment for spinal muscular atrophy

Midway receives funding for gastrointestinal therapy development program

Peptech acquisition strengthens company's product pipeline

Health Canada approves Aromasin for adjuvant sequential therapy in early-stage breast cancer

Orion and Abbott consider continued development of levosimendan

Bristol-Myers Squibb discontinues muraglitazar development

Promising phase II results reported for leuprolide in Alzheimer's disease treatment

Therapeutic agents for respiratory disorders described in recent patents

Recent patents disclose new therapeutics for psychological disorders

Remicade approved as first biologic treatment for active pediatric Crohn's disease

Agents for arthritis and other inflammatory disorders reported

Prostaglandin D2 receptor 1 antagonist effective in reducing nicotinic acid-induced vasodilation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...